Business Information
The group's principal activity is to design, develop, manufacture and market thinprep(R) system and thinprep imaging system for use in medical diagnostic applications. The group's thinprep(R) systems used for cervical cancer screening and non-gynaecologic cytology. The thinprep system consists of the thinprep pap test, thinprep 2000 processor and thinprep 3000 processor. The thinprep also consist of related reagents, filters and other disposable supplies. The thinprep imaging system is a device that uses computer-imaging technology to assist in primary cervical cancer screening of thinprep pap test slides. The group has operations in North America, Europe, Australia and Asia. On 24-Mar-2004, the group acquired novasure(R) system.
|
|
Name |
Title
|
Email
|
| Monroe Trout | Honorary Chmn. Emeritus | N/A | | Patrick Sullivan | Chmn., CEO, Pres. | N/A | | William McDaniel | Vice Chmn. | N/A | | David Harding | Pres. - Cytyc International, Sr. VP
| N/A | | Tony Kingsley | Pres. - Diagnostic Products Division, Sr. VP
| N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 608,250 | 139,537 | | 2005 | 508,251 | 113,486 | | 2004 | 393,593 | 73,588
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
